Donaldson Company, Inc. Share Price Mexican S.E.

Equities

DCI *

US2576511099

Environmental Services & Equipment

End-of-day quote Mexican S.E. 23:00:00 15/03/2023 GMT 5-day change 1st Jan Change
1,210 MXN +1.73% Intraday chart for Donaldson Company, Inc. -.--% -.--%

Financials

Sales 2024 * 3.58B 60.9B 281B Sales 2025 * 3.77B 64.17B 296B Capitalization 8.74B 149B 687B
Net income 2024 * 400M 6.81B 31.43B Net income 2025 * 438M 7.46B 34.42B EV / Sales 2024 * 2.54 x
Net Debt 2024 * 350M 5.96B 27.49B Net Debt 2025 * 233M 3.96B 18.28B EV / Sales 2025 * 2.38 x
P/E ratio 2024 *
22.1 x
P/E ratio 2025 *
20 x
Employees 13,000
Yield 2024 *
1.38%
Yield 2025 *
1.45%
Free-Float 78.92%
More Fundamentals * Assessed data
Dynamic Chart
3 years
952.52
Extreme 952.52
1 217.30
5 years
952.52
Extreme 952.52
1 217.30
10 years
952.52
Extreme 952.52
1 217.30
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 31/12/95
Director of Finance/CFO 57 07/12/15
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 72 25/03/10
Director/Board Member 65 17/03/16
Director/Board Member 60 26/01/22
More insiders
Donaldson Company, Inc. provides technology-led filtration products and solutions, serving a range of industries and advanced markets. The Company operates in three segments: Mobile Solutions, Industrial Products, and Life Sciences. The Mobile Solutions segment consists of the Off-Road, On-Road and Aftermarket business units. Its products include replacement filters for both air and liquid filtration applications as well as exhaust and emissions. The Industrial Solutions segment consists of the Industrial Filtration Solutions (IFS) and Aerospace and Defense business units. The products under IFS business units include dust, fume and mist collectors and air filtration systems for gas turbines. The Life Sciences segment consists of micro-environment gas and liquid filtration for food, beverage and industrial processes, bioprocessing equipment. The Company also offers biomanufacturing solutions for cell and gene therapy research, development, and commercial manufacturing.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
72.63 USD
Average target price
71.17 USD
Spread / Average Target
-2.01%
Consensus